FTSE 100 movers: Shire and Astra take a hit
Drug groups Shire and AstraZeneca are lower are reporting their first quarter results. While Shire posted a strong rise in revenues and profits in the period, sentiment seems to have been hit by sector peer Astra which cited US healthcare reform measures and generic competition as the reasons why it
Read more